Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Pharmos (PARS) -- Ignore unavailable to you. Want to Upgrade?

To: David Israel-Rosen who wrote (173)	11/10/1998 7:23:00 PM
From: Ariella	Read Replies (1) \| Respond to of 1386

David, one time I would like to hear you acknowledge that PR/IR has actually improved over the past six months (it has - read the old releases). Yes, there is room for improvement, but our internal IR person wasn't even with the firm when Alrex & Lotemax got their FDA approvals and our ourside PR firm is with PARS less than 10 weeks. It's early to lose faith in them. One should also not assume nothing is happening in the realm of IR just because it's not public -- some things do happen behind the scenes. This for instance -- today I got a telephone call from the account exec in charge of PARS at Ruder Finn, our outside PR/IR firm. He called me because my capital management firm's name was listed along with my name on the list of people who participated in the recent conference call. He was, in other words, methodically cold calling people/firms unknown to Ruder Finn in a very deliberate outreach to the buyside. I was suitably impressed. One doesn't let such a serendipitous moment pass, of course, so I introduced myself in relationship to the threads on SI and Yahoo. We had a very long chat and now the feedback so many people have privately given to me and the sentiments voiced on the threads have been given directly to to the person in charge of promoting PARS at Ruder Finn. I expect this material will be used to help make editorial decisions about how the message of PARS is getting through/not getting through to the public. This is a major step in our effort to let the company know what kinds of information the company is giving that helps investors come aboard and stay aboard. Now, when you invest in a company, you do it assuming that management will do the right thing in terms of increasing shareholder value. PARS is doing many things right -- management has its collective nose to the grindstone trying to make a deal for HU-211. I also know for a fact that at least one senior official makes the rounds of Wall Street a few times a month talking to fund managers, trying to interest them in the stock. Maybe his job will get a little easier now that AGIS has taken its position. Professional money managers have herd mentality too sometimes -- no one wants to be first. It's not easy moving a stock with so many shares outstanding. But consider this: Haim Aviv 3 % of shares outstanding; AGIS has 5%; Grace Brothers (linked to BTGC) may still have around 5%. Members of the thread on SI have about 6%. Well, look at that! 19% of the shares in strongish hands. The float edges smaller to around 30 million shares, still big, but not as big as before.... Nice to see the stock price breathe a little, isn't it? -Ariella

To: David Israel-Rosen who wrote (173)	11/11/1998 5:17:00 AM
From: Omer Shvili	Respond to of 1386

David, I didn't say your comments about several releases are BS. I said that its BS saying that the management cares less about shareholders, and that its doing a poor job. I know many companies put out more than one release, and PARS should consider doing the same. However, I don't think that 3 press releases instead of one announcing the Q3 results would have taken the stock to $4. I do know that management is listening (reading), and that in the future they'll probably take your advice of issuing multiple releases in order to get the news out. See you next week, Omer